In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

For patients undergoing prostate radiotherapy, acute toxicity is associated with late toxicity and decrement in qua ...

Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known ...

GEM Hospital's 'GEM Oncoshield' initiative offers free second opinions and advanced treatments for cancer patients nationwide in February.